# Exozymes Inc.: insider transactions

EXOZ · Nasdaq · CIK 2010788 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/exoz.md) · [Financials](/companies/exoz/financials.md) · [Filings](/companies/exoz/filings.md) · [Insiders](/companies/exoz/insiders.md)

## All transactions: 3

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-12 | [Perriman Damien Alan](/insiders/2096714.md) | Chief Commercial Officer, Officer | Sale (S) | 3,729 | $5.2096 | $19.4k | [Form 4](/filings/0001493152-26-048493.md) |
| 2026-10-09 | [Perriman Damien Alan](/insiders/2096714.md) | Chief Commercial Officer, Officer | Option exercise (M) | 3,922 | not reported | not reported | [Form 4](/filings/0001493152-26-048493.md) |
| 2024-11-08 | [MDB Capital Holdings, LLC](/insiders/1934642.md) | 10% owner | Conversion (C) | 122,657 | $6.40 | $785.0k | [Form 4](/filings/0001493152-24-046627.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 15:02 ET. No prices; not investment advice.